Logo
Racura Oncology InvestorHub

Race Oncology’s Board of Directors Roundtable

Join the Race Oncology Board for an in-depth roundtable discussion on the company’s mission, scientific breakthroughs, and strategic roadmap. Hear from Dr Peter Smith, Dr Serge Scrofani, Dr Megan Baldwinand and Dr Daniel Tillett as they explore:

  • How Race Oncology’s patient-focused mission drives decision-making

  • Recent milestones, including IP advancements and mechanism of action insights

  • The evolving oncology landscape and Race’s unique position

  • Commercial opportunities, partnering strategies, and global ambitions

  • Personal reflections from board members on resilience, governance, and innovation

This conversation offers a rare behind-the-scenes look at how Race Oncology is shaping the future of cancer treatment.

Watch here: https://youtu.be/nfM6VTBTwYQ


0

likes

0

questions

0

company answers

Ask a question


Your question will be sent privately to Racura Oncology. The company may choose to make this question public.

Investor Q&As

Start the conversation

Ask Racura Oncology a question about this update.